DISC MEDICINE INC (IRON)

US2546041011 - Common Stock

48.46  +0.03 (+0.06%)

After market: 48 -0.46 (-0.95%)

DISC MEDICINE INC

NASDAQ:IRON (9/27/2023, 7:00:02 PM)

After market: 48 -0.46 (-0.95%)

48.46

+0.03 (+0.06%)

Chartmill TA Rating
Chartmill Setup Rating
Sector
GICS SectorHealth Care
GICS IndustryBiotechnology
Chartmill FA Rating
Valuation
Growth
Profitability
Health
Dividend
Overview
Earnings (Last)08-11 2023-08-11/bmo
Earnings (Next)11-08 2023-11-08/bmo
Ins Owners35.1%
Inst Owners85.42%
Market Cap1.11B
Shares22.88M
PEN/A
Fwd PEN/A
Dividend YieldN/A
Analysts86.67
IPO08-12 2020-08-12
Stock Screener Links
Screen Image

Nasdaq Stock Screener

Find more stocks on Nasdaq

Screen Image

USA Stock Screener

Find more stocks on the USA

Screen Image

GICS Sector Stock Screener

Find competitors from the same sector on the USA

Screen Image

GICS Industry Stock Screener

Find competitors from the same industry on the USA

Screen Image

Technical Stock Screener

Find stocks with similar TA and Setup ratings on the USA

Screen Image

Fundamental Stock Screener

Find stocks with similar Fundamental rating on the USA

Screen Image

Best Technical Competitors Stock Screener

Find the competitors with the best technical ratings on the USA

Screen Image

Best Technical Setups Competitors Stock Screener

Find the competitors with the best technical and setup ratings on the USA

Screen Image

Best Fundamental Competitors Stock Screener

Find the competitors with the best fundamentals on the USA

Screen Image

Best Valuation Competitors Stock Screener

Find the competitors with the best valuation on the USA

Screen Image

Best Dividend Competitors Stock Screener

Find the competitors with the best dividend on the USA

Screen Image

Best Analyst Rating Competitors Stock Screener

Find the competitors with the best analyst ratings on the USA

IRON Daily chart

Company Profile

Disc Medicine, Inc. operates as a biopharmaceutical company. The company is headquartered in Watertown, Massachusetts and currently employs 46 full-time employees. The company went IPO on 2020-08-12. The firm is primarily engaged in discovering, developing, and commercializing treatments for patients who suffer from serious hematologic diseases. The company is building a portfolio of therapeutic candidates that focuses to address a spectrum of hematologic diseases by targeting fundamental biological pathways of red blood cell biology, specifically heme biosynthesis and iron homeostasis. Its pipeline includes bitopertin, which is for the treatment of erythropoietic porphyrias (EPs), including erythropoietic protoporphyria (EPP), X-linked protoporphyria (XLP) and Diamond-Blackfan Anemia (DBA); DISC-0974 for the treatment of anemia of myelofibrosis (MF), and anemia of chronic kidney disease (CKD); MWTX-003 for the treatment of polycythemia vera (PV), and other hematologic disorders. In addition, its preclinical programs also include DISC-0998, which is for the treatment of anemia associated with inflammatory diseases.

Company Info

DISC MEDICINE INC

321 Arsenal Street, Suite 101

Watertown MASSACHUSETTS

P: 16176749274.0

Employees: 46

Website: https://www.discmedicine.com/

IRON News

News Image7 days ago - Seeking AlphaDisc Medicine stock up on FDA Fast Track tag (NASDAQ:IRON)

Disc Medicine (IRON) said Wednesday the U.S. FDA granted Fast Track Designation for its blood cancer drug MWTX-003 as a treatment for polycythemia vera. Read more here.

News Image7 days ago - Disc Medicine IncDisc Medicine Receives FDA Fast Track Designation for MWTX-003 for the Treatment of Polycythemia Vera
News Image7 days ago - Disc Medicine IncDisc Medicine Receives FDA Fast Track Designation for MWTX-003 for the Treatment of Polycythemia Vera

WATERTOWN, Mass., Sept. 20, 2023 (GLOBE NEWSWIRE) -- Disc Medicine, Inc. (NASDAQ:IRON), a clinical-stage biopharmaceutical company focused on the...

News Image22 days ago - Market News VideoNoteworthy Tuesday Option Activity: NXGN, IRON, DOOR
News Imagea month ago - Disc Medicine IncDisc Medicine to Participate in Upcoming Investor Conferences
News Imagea month ago - Disc Medicine IncDisc Medicine to Participate in Upcoming Investor Conferences

WATERTOWN, Mass., Aug. 30, 2023 (GLOBE NEWSWIRE) -- Disc Medicine, Inc. (NASDAQ:IRON), a clinical-stage biopharmaceutical company focused on the...

IRON Twits

Here you can normally see the latest stock twits on IRON, but your cookie settings prevent this from loading. You can edit your cookie settings in our cookie consent dialog.

Example Twits:

Twits example